Search
Search Results
##search.searchResults.foundPlural##
-
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1585PDF: 1046HTML: 238 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3206PDF: 1173HTML: 408 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2782PDF: 980HTML: 4710 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3677PDF: 1404HTML: 3780Letter to Editor: 195 -
AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA
2829PDF: 909HTML: 381Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 200 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1806PDF: 1088HTML: 259 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2324PDF: 1170HTML: 652 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2480PDF: 1250HTML: 3609Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 414 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4117PDF: 1265HTML: 1963Table 1: 204 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1489PDF: 891HTML: 320 -
PREVALENCE OF ALPHA THALASSEMIA IN MICROCYTIC ANEMIA: A TERTIARY CARE EXPERIENCE FROM NORTH INDIA
2453PDF: 1240HTML: 4740table: 214fig 1: 224fig 2: 180 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1021PDF: 556HTML: 7816 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4841PDF: 1798HTML: 2724Untitled: 227 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3268PDF: 1592HTML: 267 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3412PDF: 1306HTML: 1908Fig.1: 206Fig. 2: 217 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1407HTML: 477PDF: 836 -
MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS
1551PDF: 908HTML: 1438Table: 197 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1632PDF: 516HTML: 247 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5196PDF: 1341HTML: 2756Cover letter: 201 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3355PDF: 1369HTML: 2676 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3318PDF: 1257HTML: 8125 -
Parasitic hypereosinophilia in childhood: a diagnostic challenge
2602PDF: 820HTML: 307Figure 1: 173 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1560PDF: 891HTML: 988figures: 188table 1: 189table2: 185table3: 190 -
Acquired Hemophilia A successfully treated with rituximab
2025PDF: 1156HTML: 1459Figure 1: 183 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2006PDF: 735HTML: 688Table1: patient's characteristics: 160Table 2: profile of each patient: 184 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1323PDF: 1023HTML: 125 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1326PDF: 739HTML: 330 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1813PDF: 715HTML: 404 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3597PDF: 2520HTML: 1499







